Use of novel and conventional biomarkers for management of patients with heart failure

被引:5
作者
Schlendorf K.H. [1 ]
Kasper E.K. [1 ]
机构
[1] Johns Hopkins Hospital, Baltimore, MD 21287, Blalock 536
关键词
Heart Failure; Natriuretic Peptide; Brain Natriuretic Peptide; Acute Decompensated Heart Failure; Brain Natriuretic Peptide Level;
D O I
10.1007/s11936-011-0150-9
中图分类号
学科分类号
摘要
Opinion statement: Investigation of the complex biochemical pathways that underlie heart failure (HF) has led to the recognition of multiple molecular markers that may help to characterize patients with this disease. Although a myriad of novel biomarkers are being studied, most attention continues to be focused on the natriuretic peptides, brain natriuretic peptide (BNP) and N-Terminal-proBNP (NT-proBNP). Numerous studies have established a role for these hormones in HF diagnosis and prognostication. More contentious has been their role in helping to guide HF management on a routine basis. This article aims to update the body of evidence surrounding conventional HF biomarkers and to highlight some emerging evidence on the use of novel markers. We believe that in select patients there may be a role for monitoring and cautious interpretation of HF biomarker levels to facilitate diagnosis, prognostication, and optimization of tailored therapy. However, there are not yet convincing data to suggest that routine hormone monitoring should be applied broadly and algorithmically to all HF patients. Moreover, to the extent that they are measured, HF biomarkers should serve only as a complement to-never as a substitute for-sound clinical judgment, watchful follow-up, and reliance on expert consultation when necessary. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:475 / 488
页数:13
相关论文
共 50 条
[31]   Using Biomarkers to "Guide" Heart Failure Management: Current Perspectives and Future Directions [J].
Motiwala, Shweta R. ;
Januzzi, James L., Jr. .
CARDIOLOGY IN REVIEW, 2013, 21 (03) :127-134
[32]   Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment? [J].
Peeters, J. M. P. W. U. ;
Sanders-van Wijk, S. ;
Bektas, S. ;
Knackstedt, C. ;
Rickenbacher, P. ;
Nietlispach, F. ;
Handschin, R. ;
Maeder, M. T. ;
Muzzarelli, S. F. ;
Pfisterer, M. E. ;
Brunner-La Rocca, H. P. .
NETHERLANDS HEART JOURNAL, 2014, 22 (03) :115-121
[33]   Novel biomarkers in chronic heart failure [J].
Ahmad, Tariq ;
Fiuzat, Mona ;
Felker, G. Michael ;
O'Connor, Christopher .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (06) :347-359
[34]   Novel Biomarkers of Heart Failure in Pediatrics [J].
Kojc, Teja Senekovic ;
Varda, Natasa Marcun .
CHILDREN-BASEL, 2022, 9 (05)
[35]   Novel biomarkers in acute heart failure [J].
Yanavitski M. ;
Givertz M.M. .
Current Heart Failure Reports, 2011, 8 (3) :206-211
[36]   Novel biomarkers in heart failure: an overview [J].
Dalzell, Jonathan R. ;
Jackson, Colette E. ;
McDonagh, Theresa A. ;
Gardner, Roy S. .
BIOMARKERS IN MEDICINE, 2009, 3 (05) :453-463
[37]   Management of Chronic Heart Failure: Biomarkers, Monitors, and Disease Management Programs [J].
Gandhi, Parul U. ;
Pinney, Sean .
ANNALS OF GLOBAL HEALTH, 2014, 80 (01) :46-54
[38]   The Use of Biomarkers in the Patient with Heart Failure [J].
Punam Chowdhury ;
Devin Kehl ;
Rajiv Choudhary ;
Alan Maisel .
Current Cardiology Reports, 2013, 15
[39]   Use of multiple biomarkers in heart failure [J].
Allen L.A. .
Current Cardiology Reports, 2010, 12 (3) :230-236
[40]   Conventional Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease [J].
Manescu, Ion-Bogdan ;
Pal, Krisztina ;
Lupu, Silvia ;
Dobreanu, Minodora .
LIFE-BASEL, 2022, 12 (12)